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Abstract 
Purpose: To investigate a pixel densitometry index (PDI) for measuring ocular surface 
inflammation (OSI). 
Methods: Efron’s grading was performed by two independent observers. Color photographs and 
indocyanine green angiography (ICGA) were undertaken before and after instillation of 
phenylephrine hydrochloride 2.5% (PE).  
Results: Fifteen patients with and 10 without OSI were included. The reduction in the PDI before 
and after PE was 73.29 ± 30.71 and 50.87 ± 17.46 (p = 0.036) in patients with inflammation and 
52.86 ± 16.90 and 39.63 ± 12.04 (p = 0.0024) in those without OSI.  The reduction in Efron grades 
following PE was 25% (mean 0.46± 0.50, median 0.50; p<0.01). The coefficient of variation was 
higher using the Efron grades (131%) than the PDI (65%). 
Conclusion: The PDI allows the objective detection of change in conjunctival hyperemia and may 
be directly applicable to non-invasive angiography such as optical coherence tomography based 
angiography. 
 
 
Introduction 
Hyperemia caused by vascular injection of the bulbar conjunctiva and subconjunctival vessels is a 
key feature of ocular surface inflammation (OSI). OSI in clinical routine is usually graded 
subjectively based on biomicroscopic findings.1,2 Clinical grading of OSI is crucial for disease 
monitoring and the evaluation of treatment efficacy. Objective and repeatable assessment is of 
particular importance in clinical settings where consecutive patients need to be closely followed 
by more than one clinician and for monitoring systemic immunosuppressive medication, for 
example, in chronic allergic eye disease, graft-versus-host disease, and cicatrizing conjunctivitis. 
Different qualitative and quantitative grading scales including semi- or fully automated methods 
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have been proposed to measure conjunctival vascular injection. The grading scales proposed by 
Efron and McMonnies, which provide a score depending on the number, density, and tortuosity of 
vessels, are among the scales most frequently used in clinical routine.1,2 As with all qualitative or 
semi-quantitative methods, however, these classifications exhibit considerable variability among 
different observers3 or by the same observer over time.4 Most of the available semi-automated 
techniques are based on a combination of color quantification,5AD edge detection,6 and fractal 
analysis.9 These methods, however, have not been adapted widely in clinical practice due to 
several disadvantages, including limited availability and setup costs of dedicated instruments, the 
need of special training for graders, and the amount of time needed to analyse images. The advent 
of optical coherence tomography based anterior segment angiography (OCTA) now allows the 
non-invasive three-dimensional depiction of ocular surface vasculature, although still limited by 
artefacts.10,11 In order to provide proof of concept, in this pilot study we investigated and 
compared angiographic pixel densitometry with the Efron grading scale to measure ocular surface 
vascular injection. In order to further evaluate and compare these methods to detect change, 
vasoconstriction was induced with topical phenylephrine. 
 
Methods 
Patients with OSI resulting from multiorigin conjunctivitis and or keratitis (study group) and 
patients with corneal neovascularisation (CoNV) in the fellow eye were included. Written informed 
consent was obtained from all subjects, and the study was performed according to the tenets of 
the Declaration of Helsinki with institutional review board approval. Standardized patient 
demographic and clinical data sheets were used to record age, race, sex, diagnosis, visual acuity 
(best-corrected visual acuity), previous ocular medical or surgical treatment, and the presenting 
clinical features of the ocular surface disease including the cause and duration of the current 
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episode of ocular inflammation. Patients with any contraindications to undergo ICGA (known 
allergy to iodides and shellfish, inability to fixate on a target, or continuous eye movements such 
as nystagmus) were excluded. The occurrence of adverse events and reactions was documented. 
Color photographs and indocyanine green angiography (ICGA) of the ocular surface were 
undertaken on each patient. 
Color images were recorded using a slit-lamp mounted digital system (Topcon SL-D Digital Slit 
Lamp) using a 6 times magnification in four sections:  Nasal, temporal, superior and inferior 
conjunctival quadrant. Illumination was from a 45 degree angled beam on slit lamp biomicroscopy 
with a diffuser filter and a variable flash intensity. Color photographs were saved in tiff format at 
an image dimension of 4,256 x 2,832 and 300 pixels per inch. Following color photography, 
angiographic images were recorded with red-free, infrared, and fluorescent filters (ICG: 825 nm) 
using the Heidelberg system with 20 and 30 degree angle lenses and between 32D and 53D focus. 
Preceding dye injection for angiography, images were taken with an ICG filter to exclude other 
causes of hyperfluorescence. After administration of 2.5 mL of 5mg/ml indocyanine green (ICG, 
Pulsion Medical Systems, Munich, Germany), a video was taken for 60 seconds (early ICG phase) of 
the superior bulbar conjunctiva, commencing 10 seconds after the injection.12 Representative 
color photographic and ICG angiographic images are shown in figure 1. We have previously shown 
that the inferior (I) quadrant of the cornea fills first followed by the superior (S), nasal (N), and 
temporal (T) quadrants (ISNT)12.  Single images were taken for up to 3 minutes. 2.5% 
phenylephrine (PE) eye drops were then instilled and after 5 minutes, color photography was 
repeated, and a further injection of 2.5 ml of ICG and ICGA images were again recorded for 3 to 5 
minutes. 
 
Analysis  
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Video and still pictures taken immediately after the injection of ICG were analysed independently 
by two observers (VR and BS). Color images were analysed for quality and clarity of conjunctival 
vasculature. The best color photographs and ICGA images obtained between 60 and 120 sec after 
the first and second injection of ICG were independently selected by same two observers  based 
on the following previously published qualitative subjective parameters:12 Specifically, the best 
ICGA images were selected based on the following qualitative subjective parameters. Quality 
grading for ICGA was categorized as 0 to 4 (0, no vessel discernible; 1, poor vessel delineation; 2, 
good vessel delineation; 3, very good vessel delineation; 4, excellent vessel delineation).12 The 
images with good vessel delineation would have at least 50% of vessels clearly evident with 
distinct boundaries and hyperfluorescence. A square-shaped region of interest (ROI) of 3x3 mm 
was chosen in the superior bulbar conjunctiva, and the same ROI was marked on both color 
photographs and ICG angiograms before and after PE. The superior conjunctival quandrant was 
chosen in order to analyse an area with the lowest likelihood of vascular anomalies secondary to 
degenerative conjunctival changes as e.g. pinguecula. Additionally, the degree of conjunctival 
vascular injection in other quadrants is expected to be more affected by environmental factors or 
lid margin pathology as potential bias to PDI results when monitoring ocular surface inflammation 
(OSI).  
For analysis of color photographs, blood vessels within the ROI were extracted by an established 
segmentation method.13 The ratio between the number of vessel pixels and total pixel number 
within the ROI was computed.  For Efron grading, a selected color photograph before and after PE 
from each patient was analysed and graded independently by VR and BS. For analysis of ICG 
angiograms, the alignment of pre- and post-PE images was attempted using i2k Retina software 
(DualAlign LLC, Clifton Park, NY), but this could not be achieved with this software. The mean 
intensity (±standard deviation) of the pixels in the ROI was defined as the pixel densitometry index 
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(PDI). 
Statistical analysis was performed using the Statistical Package for the Social Sciences Software 
(IBM SPSS Version 22.0 for MAC; SPSS Inc., Chicago, IL). P values of less than 0.05 were considered 
statistically significant. Data are presented as mean values ± standard deviations. Non-parametric 
tests (Kruskal-Wallis and Wilcoxon signed rank test) were used to compare clinical grading scores. 
Levels of agreement were tested using Fleiss' Kappa Statistic (k).  Interpretation of levels of 
agreement were be based on that described for two (binary) categories for each patient. A value 
of <0.2, k was considered poor, 0.2< k < 0.4 fair; 0.4 < k < 0.6 moderate, 0.6 < k < 0.8 substantial 
and k > 0.8 as almost perfect. 
 
Results 
Fifteen patients with bulbar conjunctival redness of variable origin and duration and 10 patients 
with CoNV in the fellow eye but with no clinical evidence of OSI or history of inflammation in the 
studied eye were included. The demographic features and clinical details are summarized in Table 
1. The mean patient age at presentation was 42.3 ± 17.1 years (min: 21 years and max: 75 years). 
In patients with inflammation the mean duration of conjunctival hyperemia was 4 days (min: 2 –7 
days). The mean visual acuity was 0.30 ± 0.33 LogMAR (min: -0.10  and max: 1) and 0.1 ±  0.18 in 
patients with and without ocular surface disease. The most common aetiology of bulbar 
conjunctival hyperemia were microbial keratitis (9/15), atopic keratoconjunctivitis (3/15), and 
episcleritis and scleritis (3/15). Intravenous application of ICG was well tolerated and no any 
adverse event to angiography occurred.  
The level of inter-observer agreement using Efron’s grading was poor before PE (k=0.21) but 
moderate after PE (k=0.45). There was, however, substantial inter-observer agreement on the 
difference before and after PE (k=0.65).  There were significant differences between patients with 
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and without inflammation using Efron’s grading 2.93 ± 0.89 [min: 1.50, max: 4.00] versus 0.90 ± 
0.39 [min: 0, max: 1.5 p < 0.001) and the PDI 73.29 ± 30.71 (min: 36.48, max: 130.19) versus 52.87 
± 16.90 (min: 34.62, max: 77.08 p = 0.04).  The PDI using the color images (ratio between the 
number of vessel pixels and total pixel number) gave a very low ratio (mean 0.114 ± 0.04). 
There was a significant reduction in vascular injection following the instillation of PE in all subjects. 
The overall PDI of all cases before and after instillation of PE was 65.11 ± 27.60 and 44.87 ± 22.48. 
(p = 0.002) The PDI before and after PE in patients with inflammation was 73.29 ± 30.71 and 48.49 
± 27.60 (p = 0.004), and 52.87 ± 16.90 and 39.44 ± 10.22 (p = 0.0024) in those without.  The mean 
overall Efron grading before PE was 2.12 ± 1.24 and after PE was 1.66 ± 1.19 (p= 0.07) (table 2). 
The coefficient of variation (SD/mean x 100) both pre and post phenylephrine was lower using the 
PDI (42% and 50%) than with the Efron grades (59% and 72%). 
The mean reduction in Efron grades following PE was 25% (mean 0.46± 0.50, median 0.50; 
p<0.01), and of PDI units was 29% (mean 20.25± 20.85, median 15.84; p<0.01).  There were 
significant linear associations between the grade of inflammation pre and post PE for both Efron 
(R2=0.95, b=0.81, p<0.01) and the PDI (R2=0.89, b=0.67, p<0.01), reflecting a 33% change following 
PE for the PDI and 19% using the Efron grades (figure 2).  
  
Discussion 
We report a method to objectively quantify ocular hyperemia using densitometric analysis of early 
ICG angiographic images.  The PDI is calculated from the number of white and black pixels in 
analysed images, where vessels with dye are seen as white pixels. For image comparison either 
longitudinally or following PE as in this study, and different from previous reports,5,14,15 the 
presented system is based on digital vessel alignment and subtraction analysis providing a less 
operator dependent method. This avoids the need for white balance standardization of a 
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photograph, which introduces a level of subjectivity when the observer selects a white spot on the 
images for the purpose of color balance adjustment. ICGA densitometry also enables quantitative 
analysis. Furthermore the use of a continuous scale of measurement lends simplicity to the clinical 
interpretation of the results and allows for more analysis of the data using continuous rather than 
ordinate or nominal scales.  
In order to assess the feasibility and sensitivity of this method to detect and measure intra-
individual change, we used topical phenyephrine to constrict the superficial ocular surface 
vasculature. Topical PE led to a smaller reduction and with greater variability using the Efron 
grades than with the PDI for both patients with and without OSI. The coefficient of variation using 
the Efron grades was higher than that with the PDI.  This may be due to the difference in scales 
but may also indicate that the PDI may be subject to less variability. The PDI does not carry the 
limitation of inter-observer variability, reducing the need for a clinically trained grader. This is a 
weakness of many commonly used grading scales such as McMonnies and Efron,1,2 who suggested 
the use of photographic reference scales to grade conjunctival hyperemia when recording the 
level of severity of ocular complications of contact lens wear. Observer experience significantly 
improved grading reliability in these widely used grading scales16,17 which are also limited by a high 
inter- and intra-observer variability.3,4  
We reported previously that the anterior segment angiography is useful tool in grading of ocular 
surface disease including corneal neovascularization atopic keratoconjunctivitis.18–20 Our results 
suggest that densitometric analysis of conjunctival angiograms has the potential to be useful for 
monitoring OSI. ICGA was well tolerated by all study subjects, which is in line with previous data 
showing ICG to be much better tolerated and to carry a lesser risk of anaphylactic reactions 
compared to fluorescein dye (0.05 %vs 0.3 %).21,22  
We included the uninvolved fellow eyes of patients with CoNV as representative of patients 
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without inflammation.  Although there was no clinically apparent inflammation (hence Efron grade 
of zero), there may have been circulating cytokines from the disease (CoNV) in the fellow eyes 
leading to increased vessel flow in the apparently un-inflamed eye and a higher PDI. 
As a limitation at this stage, the creation of a fixed PDI grading scale is difficult because of inter-
individual differences in vessel characteristics. Currently the PDI may not therefore be as 
amenable to inter-patient comparison compared to color image comparison. In contrast to 
angiography, we did not find the PDI to be informative using color images possibly due to reduced 
small vessel detection with color photographs compared to angiography. It would be feasible to 
further standardize ICGA for measurement of the PDI in additional to the standardized scanning 
protocol and with larger numbers to have clinical PDI standards. For example, in order to 
compensate variable laser power and scanning sensitivity, an internal reference could be used to 
calibrate the PDI.23 This would then enable comparisons both between and within subjects at 
different time points. Also given the limitation of the i2kRetina programme and of its kind, it is 
desirable to have an effective approach to align images before and following PE injection so as to 
analyse the exact same areas. Both of these would then enable the determination of changes over 
time or between individuals. In the clinical setting, intra-individual comparability is probably the 
relevant feature for detecting longitudinal change in ocular surface inflammatory disease. 
Our results show that ocular surface angiography based on white pixel densitometry allows the 
objective detection of change in conjunctival hyperemia. While ICGA may be considered invasive 
for routine assessment of conjunctival inflammation, this investigation serves as a proof of 
principle to establish a methodology which may be directly applicable to non-invasive angiography 
such as optical coherence tomography based angiography.10 
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Figure legends 
Figure 1. Color photo (A) and angiographic images before (C) and after (D) topical phenylephrine 
2.5%. The histogram plot (B) shows the frequency of pixels in the image (vertical axis) with a 
particular brightness value ranging from 0 to 255 (horizontal axis).  
 
Figure 2.  Measurement of ocular surface inflammation. Plot of the linear association before and 
following phenylephrine using Efron grading (A) and the PDI (B). 
 
 
